Outcomes of WHO-conforming, longer, all-oral multidrug-resistant TB regimens and analysis implications von Rich, ML, Khan, U, Zeng, C, LaHood, A, Franke, MF, Atwood, S, Bastard, M, Burhan, E, Danielyan, N, Dzhazibekova, PM, Gadissa, D, Ghafoor, A, Hewison, C, Islam, MS, Kazmi, E, Khan, PY, Lecca, L, Maama, LB, Melikyan, N, Naing, YY, Philippe, K, Saki, NA, Seung, KJ, Skrahina, A, Tefera, GB, Varaine, F, Vilbrun, SC, Võ, L, Mitnick, CD, Huerga, H

Volltext

Introducing new and repurposed TB drugs: the endTB experience von Seung, KJ, Khan, U, Varaine, F, Ahmed, S, Bastard, M, Cloez, S, Damtew, D, Franke, MF, Herboczek, K, Huerga, H, Islam, S, Karakozian, H, Khachatryan, N, Kliesckova, J, Khan, AJ, Khan, M, Khan, P, Kotrikadze, T, Lachenal, N, Lecca, L, Lenggogeni, P, Maretbayeva, S, Melikyan, N, Mesic, A, Mitnick, CD, Mofolo, M, Perrin, C, Richard, M, Tassew, YM, Telnov, A, Vilbrun, SC, Wanjala, S, Rich, ML, Hewison, C

Volltext